A detailed history of Rhumbline Advisers transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 412,900 shares of PACB stock, worth $796,897. This represents 0.0% of its overall portfolio holdings.

Number of Shares
412,900
Previous 436,868 5.49%
Holding current value
$796,897
Previous $598,000 17.22%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1.2 - $2.17 $28,761 - $52,010
-23,968 Reduced 5.49%
412,900 $701,000
Q2 2024

Aug 01, 2024

BUY
$1.36 - $3.65 $70,348 - $188,803
51,727 Added 13.43%
436,868 $598,000
Q1 2024

May 09, 2024

BUY
$3.52 - $9.59 $6,416 - $17,482
1,823 Added 0.48%
385,141 $1.44 Million
Q4 2023

Feb 08, 2024

BUY
$5.97 - $10.36 $1,993 - $3,460
334 Added 0.09%
383,318 $3.76 Million
Q3 2023

Nov 09, 2023

BUY
$8.23 - $13.93 $11,464 - $19,404
1,393 Added 0.37%
382,984 $3.2 Million
Q2 2023

Aug 08, 2023

SELL
$9.97 - $14.05 $218,482 - $307,891
-21,914 Reduced 5.43%
381,591 $5.08 Million
Q1 2023

May 11, 2023

BUY
$7.94 - $12.02 $353,012 - $534,409
44,460 Added 12.38%
403,505 $4.67 Million
Q4 2022

Feb 14, 2023

BUY
$5.67 - $11.2 $35,363 - $69,854
6,237 Added 1.77%
359,045 $2.94 Million
Q3 2022

Nov 10, 2022

BUY
$3.93 - $8.57 $91,682 - $199,929
23,329 Added 7.08%
352,808 $2.05 Million
Q2 2022

Aug 11, 2022

BUY
$4.02 - $10.43 $372,561 - $966,621
92,677 Added 39.14%
329,479 $1.46 Million
Q1 2022

May 12, 2022

SELL
$8.43 - $20.9 $69,732 - $172,884
-8,272 Reduced 3.38%
236,802 $2.16 Million
Q4 2021

Feb 10, 2022

SELL
$19.26 - $30.08 $60,264 - $94,120
-3,129 Reduced 1.26%
245,074 $5.01 Million
Q3 2021

Nov 12, 2021

SELL
$24.86 - $35.02 $38,980 - $54,911
-1,568 Reduced 0.63%
248,203 $6.34 Million
Q2 2021

Aug 05, 2021

BUY
$22.3 - $36.02 $765,559 - $1.24 Million
34,330 Added 15.93%
249,771 $8.73 Million
Q1 2021

May 06, 2021

SELL
$26.38 - $51.15 $225,443 - $437,127
-8,546 Reduced 3.82%
215,441 $7.18 Million
Q4 2020

Feb 10, 2021

BUY
$10.5 - $28.5 $289,674 - $786,258
27,588 Added 14.05%
223,987 $5.81 Million
Q3 2020

Nov 12, 2020

SELL
$3.61 - $9.87 $54,449 - $148,869
-15,083 Reduced 7.13%
196,399 $1.94 Million
Q2 2020

Aug 13, 2020

BUY
$2.65 - $4.03 $45,370 - $68,997
17,121 Added 8.81%
211,482 $730,000
Q1 2020

May 06, 2020

SELL
$2.36 - $5.26 $16,800 - $37,445
-7,119 Reduced 3.53%
194,361 $595,000
Q4 2019

Feb 05, 2020

BUY
$4.6 - $5.57 $14,733 - $17,840
3,203 Added 1.62%
201,480 $1.04 Million
Q3 2019

Oct 23, 2019

BUY
$4.99 - $6.16 $11,626 - $14,352
2,330 Added 1.19%
198,277 $1.02 Million
Q2 2019

Aug 14, 2019

BUY
$5.92 - $7.41 $92,085 - $115,262
15,555 Added 8.62%
195,947 $1.19 Million
Q1 2019

May 01, 2019

BUY
$6.8 - $7.4 $36,475 - $39,693
5,364 Added 3.06%
180,392 $1.3 Million
Q4 2018

Jan 31, 2019

BUY
$3.99 - $7.82 $259,110 - $507,830
64,940 Added 58.99%
175,028 $1.3 Million
Q3 2018

Nov 07, 2018

SELL
$3.52 - $5.55 $24,189 - $38,139
-6,872 Reduced 5.88%
110,088 $596,000
Q2 2018

Aug 06, 2018

BUY
$2.11 - $3.92 $35,880 - $66,659
17,005 Added 17.01%
116,960 $415,000
Q1 2018

May 02, 2018

SELL
$2.05 - $3.23 $2,367 - $3,730
-1,155 Reduced 1.14%
99,955 $205,000
Q4 2017

Feb 09, 2018

SELL
$2.59 - $5.44 $19,357 - $40,658
-7,474 Reduced 6.88%
101,110 $267,000
Q3 2017

Nov 06, 2017

BUY
$3.2 - $5.57 $347,468 - $604,812
108,584
108,584 $570,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $434M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.